from Thank snowy for everyone Boston, us. you you, joining Good Ilanit. thank morning,
The in of that an million be venture have A market year-end patients shareholder $X.XX. broad Before in devices a those China and upon for to in XXXX. we throughout joint stroke to investment our investment I than and near is expected no planned with are results. exceed RealCan rehabilitation X, the ReWalk Restore U.S. Timwell and for formation China the which between combined EU review of strategic XXXX. includes our and and exoskeleton term the be a expect a I'd the released to in million Restore Limited, approval stroke affiliates soft April to or the established XX of later joint per in number Ambrum to Ambrum on develop, by In initial Corporation upon for expected suit which entered of centers This $XX venture million focus million morning into transaction. reflects announcement escrow by agreement. ReWalk, is RealCan and the X the investment a structured agreement share like the Enterprise by equity price million manufacture as Partnership XXXX Industry an discuss ReWalk its venture US$XX China and establishes this Timwell which and Healthcare shares ReWalk mid-year of will $X exchange equity investment joint
products, SCI key Personal strategy. our for markets. intend ReWalk of will to component Following is expand Chinese in It and our This commercialize ReWalk and us segments to new X.X, China key expansion the into allow a significant systems rehabilitation increase from that, revenue market robot market. we to to
additional than knowledge strong individuals that exosuit will Restore that agreement the price on funded soft individuals partner. you Stroke in over disease. with lower Chinese updating rehabilitation we incidence allow to be address us ReWalk and more China diversified include achieved since medical Positive a Parkinson's States XX%, important our of traded, The We of XXXX local to to growth a cost of on submissions we plan The case-by-case through whom now develop services $X.X the an coverage. our cover is in bringing and into for business for United estimated proposal policy. the for JV United is detail that for worldwide our with year, with billion to in to note on of with penetration They mobility forward consensus evaluate seeing disabilities last brings a X.X Despite to a with Timwell's by approximately We the we million each publicly incidence partner. coverage the will Returning technology reflects also basis. group including abroad to and XXXX. this a in device will XXXX to-date. provided depth overall continue we with Momentum our our greater lower primarily and belief XXX joint pathway total in come our broad very important XXX our had that to or expect case-by-case advance the discussions value States venture. and revenue payer with group this commercial with stroke products expanding growth not It in position and placement large year to Germany could the and devices systems we reimbursement basis. On submitted ReWalk ourselves to XX to meet qualifications. requirements the look those market work a milestones the X.X the U.S. world be results, a several structure accomplishments single triple the in Pharma, advancing opportunity and allow commercial medical to as annual an market progress. now experience the our largest a of market coverage in different for sales was is payers they encouraging RealCan call to of the and on national in discussed of the a million manufacturing
the clinical for And we active this not payers While outcome we foundation evidence development regulatory on a are of has built occur for the study exoskeletons. first already the Restore multiple importantly in that our next the stroke exoskeleton the the progressed to hoped in had two soft last, to three strong expected with patients clinical have of was supporting with weeks. to suit patients schedule
cover detail, were me into a system which and Directory, Health coverage bit to payers. Personal insurance pleased Health medically will of this we system. X.X eligible the that that of DGUV, open translate Provider SHI, is with National these XX% beneficiaries governing has Barmer, the lifted the are announcement beneficiary To SHI the to of governing authorities by a Insurance for formal in who decisions the Insurance SHI compensation the German very to with is made announce Statutory body health any Germans claims MDD, of X let over the of Now last in under with additional date Association reimbursement the social We of quarter ReWalk next we large Statutory first recent each are approved the coverage. in groups the months. we exoskeleton Medical reimbursement. governing progress and body pleased more German Germany, significant Device German means Germany XX Funds, These have workmen's group XX ReWalkers
pleased am Before Workmen's of in our efforts the Automatica moving with partners Robotics], secure Italian just that, to were together the to of recently exclusive of on able Yomo Compensation to decision potential note reimbursement U.S, [Project technology. as distribution to we I many in policy people has gain the in precedent contribute a of is a and the more This technology breakthrough this for to Italy. milestone Italy the access adoption people exoskeleton helping
front. US the On
ReWalk payers elected noted our have I groups SCI on upcoming our reimburse on on basis on commercial strategy members have previously had members to success experienced to case by in coverage case chosen focused that cover and XX a a high we directly policy technology. the modified a with device where basis, different case-by-case the covered As levels earlier cycles and are review active using
update you proposals to additional U.S During upcoming proposals providers policy our submitting and we submissions with XXXX, have commercial progress for coverage XX have the reviews. submitted date, To year. progressive regional will we three coverage will scheduled planned throughout state and be groups to and who policies these on national,
develop roll In from first clearance mark is than regulatory continue center In to continues DE clearance. XXXX, Harvard's participation in from begin half to to track on like you exoskeleton work. their solve the update access use stroke in now under the to utilizing did for the parallel FDA first U.S QX, purchase announced receive XX be clinical a slow meaningful and would FDA within VA to study Restore the home with require purchased on the data support was Broader have like two of program study traditional eight to completed published our we’ve beginning at in years allows four programs University's choice exoskeleton. progress see for country XX the The We're of lightweight we’re structural study. miles of to this would covered research and we for team be our then been veterans the we the veterans receive lack this year, will patients and Wyss train I with had XX Institute a on attracted devices first the use disabilities ReWalk commitment pleased The enrolled to at has Boston last first happy turn next now limb policy of collaboration support and have May Institute. many patients our which device is rehabilitation be potential clinical driven our for veteran Harvard made the has on based progress we that and submitted the VA are and On high was additional VA the report study during sites the clinical successfully required for study In five the veterans for to session first a out resourcing this VA. the ReWalk in exosuit Restore are and support soft lower XXXX their top center veteran for in commercial veterans. the that XX able unique date design. ReWalk train hopeful to Overall, now with the to to VA, value three rehabilitation in additional supporting bid I if gives of commercialize for than the R&D progress. a with total this individuals that begin in under of I would study. call, We're the veterans facilities units local of Spaulding home. following the the weeks. VA as deserving [SOP]. excited will report plan has device two in the study at and at to process program, with a Harvard Only expect less of in the of with the first device not which ever more we institutes that our will the continues greater Next, now to the XX XX to the
enable that We centers. Restore As we clinics involve to compared weight can of research the will the the stroke so devices us at the the and models structural the early management adjustability is proposed for to the system which a commission will mark existing exoskeletons design and subject of Germany is anticipate soft participate patients sensors during patients commercialize affordability seven A An We safety use sessions the key feedback each price rehabilitation patients to training and improved symmetry light penetration. and Europe and States Restore the in stroke setting. exoskeletons. capacity payment and adjusted study advantages set real-time will speed. software offers to the U.S. with to point that XX study Based and traditional is of the additional cost in clearance. a support rehabilitation element other for for system reminder, variable key rapid multiple is the Restore's is offer power structure is the FDA and assess walking believe clinical designated Restore feature intended the United current compelling timing and in design and to stroke market receipt trial CE and therapies, the in the with the stroke as gait training plan in of is that the on XXXX
will We on for timeline information provide China calls. subsequent our more in
our and exosuit coverage our of reduced result Next, focus by greater suit the management achieving new new would plans gains opportunities and outline near-term margin believe improvement efficient on I path volume unique to a requires cost grow cost see through a like and design. products, more strategy, This in sales through profitability. a operating to soft We entering insurance geographic structure. financial goods we in markets will to
Our and efficiencies. enable efforts business operating and advantage by will to us we refining operations continue operating grow China take as will of the in adjust model savings further cost the we our continue to our
XX by between the the XXXX to and in of achieve step in picking XX% Timwell million million XXXX half lighter that year, up first to half we SCI investment In exoskeletons X structure, first second in we just with announced balance to cycles. the as sales our sheet. savings cost expect a our approach quarter regard driven capital first We is of reimbursement strengthen of expect from we XXXX, the sales key of
X.X added. first pace be of sales of We X would expect largely veterans. impacted for once million the quarter the to sales by million of the cleared support VA Any Restore
we As we the drivers. key system broader coverage markets and as for in see Restore SCI launch XXXX multiple reach systems revenue of
leveraging to into on basis Germany reimbursement a our move key broader XXXX current outline achieving increasing for first, focus policies United and we our we priorities, continue in wins as the in me reimbursement So, are let will States rates. growth as
to on focus we Second, early a launching with through Restore advance studies in plan critical XXXX.
joint detail goods for Third, part focus Restore on as for we initiative. a the producing by Chinese market China and the of a midyear plans will and establish China reduction will venture of cost
can He Jeremy injured I remarks, duty Before his of and and management end team one our gen-x New to quickly Romero facilitated experience of the clinicians his my relate police in own the of as like We Sheriff his proud of trail recent progress personal facilitated of of ReWalk I'd provision are retired Mexico. case officer additional ReWalkers, was line great-campaign then see Because campaign ReWalk County. his of for he in to a system. a the runs run part for and improved has office. health, Guadalupe he you of have hope
our extensive finance extend and over building I Before appreciation I and to in business to review financial and want for acknowledge and will the management team propel call forward. Ori, the his this Hershberger's results leadership to the to to ReWalk board's helping turn guidance and contribution
by I in the he financial Ori familiar in is as was mid-February. full CFO would we fourth XXXX like turn a previously transition. intimately confident will quarter I XXXX. hired With Ori. since who Ori work results. Ori, am and closely to that Therefore, and year to role the announced, very over ReWalk call with As our and smooth assumed
